Dieter Hamprecht

1.5k citations

37 papers · 961 indexed · h-index 19

Co-authors: Anthony G. M. Barrett Andrew J. P. White Mitsuru Ohkubo David J. Williams David R. Witty Peter J. O’Hanlon Calum Macleod Richard L. Jarvest
Topics: Synthetic Organic Chemistry Methods (9 papers)Receptor Mechanisms and Signaling (7 papers)Asymmetric Synthesis and Catalysis (6 papers)
Cited by: Organic Chemistry Pharmacology Toxicology
Journals: Journal of the American Chemical Society Chemical Communications Scientific Reports
Partner nations: United Kingdom Italy Germany

In The Last Decade

Dieter Hamprecht

36 papers receiving 917 citations

Peers

Countries citing papers authored by Dieter Hamprecht

Since Specialization

Citations

This map shows the geographic impact of Dieter Hamprecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Hamprecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Hamprecht more than expected).

Fields of papers citing papers by Dieter Hamprecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Hamprecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Hamprecht. The network helps show where Dieter Hamprecht may publish in the future.

Co-authorship network of co-authors of Dieter Hamprecht

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Hamprecht. A scholar is included among the top collaborators of Dieter Hamprecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Hamprecht. Dieter Hamprecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue 2025 ·Journal of Medicinal Chemistry ·Henrik K. Munch,(unknown),Jesper Mosolff Mathiesen,Per‐Olof Eriksson,(unknown),(unknown),(unknown),Oliver Demmer,(unknown),Dieter Hamprecht,Wolfgang Rist,(unknown),Achim Grube,(unknown),Lise Giehm	2
2	The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement 2025 ·Scientific Reports ·Lara Perryman,Alison D. Findlay,(unknown),Brett Charlton,Jonathan S. Foot,R. Hamilton,Dieter Hamprecht,Amar Joshi,Jessica Stolp,Craig I. Turner,(unknown),Wenbin Zhou,Begoña López,Susana Ravassa,Arantxa González,Wolfgang Jarolimek	1
3	The dual GCGR/GLP‐1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection 2024 ·Diabetes Obesity and Metabolism ·Leo Thomas,Eric Martel,Wolfgang Rist,Ingo Uphues,Dieter Hamprecht,Heike Neubauer,Robert Augustin	8
4	BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy 2022 ·Molecular Metabolism ·(unknown),Leo Thomas,(unknown),Peter Haebel,Eric J. Simon,Wolfgang Reindl,Besnik Bajrami,Wolfgang Rist,Ingo Uphues,Daniel J. Drucker,Holger Klein,Rakesh Santhanam,Dieter Hamprecht,Heike Neubauer,Robert Augustin	81
5	Potent Cholesteryl Ester Transfer Protein Inhibitors of Reduced Lipophilicity: 1,1′-Spiro-Substituted Hexahydrofuroquinoline Derivatives 2014 ·Journal of Medicinal Chemistry ·Thomas Trieselmann,Holger Wagner,Klaus Fuchs,Dieter Hamprecht,Daniela Berta,Paolo Cremonesi,Rüdiger Streicher,Gerd Luippold,(unknown),Michael Markert,Herbert Nar	24
6	The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure 2010 ·Bioorganic & Medicinal Chemistry Letters ·Ian P. Holmes,(unknown),Olivier Lorthioir,(unknown),(unknown),Andrew H. Payne,Ian Stansfield,Martyn Wood,P.M. Woollard,Charlie Reavill,(unknown),Fabrizio Micheli,Romano Di Fabio,Daniele Donati,Silvia Terreni,Dieter Hamprecht,Luca Arista,Angela Worby,Steve P. Watson	5
7	[3-Azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Dieter Hamprecht,Giorgio Bonanomi,Romano Di Fabio,Daniele Donati,Gabriella Gentile,Christian Heidbreder,(unknown),Luca Tarsi,Silvia Terreni	5
8	Dopamine D3 receptor antagonists: The quest for a potentially selective PET ligand. Part two: Lead optimization 2009 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Ian P. Holmes,Luca Arista,Giorgio Bonanomi,Simone Braggio,Francesca Cardullo,Romano Di Fabio,Daniele Donati,Gabriella Gentile,Dieter Hamprecht,Silvia Terreni,Christian Heidbreder,(unknown),Cristiana Griffante,Angela Worby	10
9	New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Giorgio Bonanomi,Simone Braggio,Anna Maria Capelli,(unknown),(unknown),Romano Di Fabio,Daniele Donati,Stefania Gagliardi,Gabriella Gentile,Dieter Hamprecht,Marcella Petrone,Stefano Radaelli,Giovanna Tedesco,Silvia Terreni,Angela Worby,Christian Heidbreder	21
10	New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-Fused and hetero-fused systems 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,Giorgio Bonanomi,Simone Braggio,Anna Maria Capelli,(unknown),Romano Di Fabio,Daniele Donati,Gabriella Gentile,Dieter Hamprecht,(unknown),Marcella Petrone,Giovanna Tedesco,Silvia Terreni,Angela Worby,Christian Heidbreder	12
11	Isoindolone derivatives, a new class of 5-HT2C antagonists: Synthesis and biological evaluation 2006 ·Bioorganic & Medicinal Chemistry Letters ·Dieter Hamprecht,Fabrizio Micheli,Giovanna Tedesco,Anna Checchia,Daniele Donati,Marcella Petrone,Silvia Terreni,Martyn Wood	44
12	5-HT2C antagonists based on fused heterotricyclic templates: Design, synthesis and biological evaluation 2006 ·Bioorganic & Medicinal Chemistry Letters ·Dieter Hamprecht,Fabrizio Micheli,Giovanna Tedesco,Daniele Donati,Marcella Petrone,Silvia Terreni,Martyn Wood	12
13	Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849 2006 ·Bioorganic & Medicinal Chemistry Letters ·David R. Witty,John H. Bateson,Guillaume Hervieu,Kamal Albarazanji,Philip D. Jeffrey,Dieter Hamprecht,Andrea Haynes,Christopher N. Johnson,Alison I. Muir,Peter J. O’Hanlon,Geoffrey Stemp,(unknown),Kevin M. Thewlis,Kim Winborn	18
14	Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: Synthesis and biological evaluation 2006 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli,(unknown),Giovanna Tedesco,Dieter Hamprecht,Giorgio Bonanomi,Anna Checchia,Albert Jaxa‐Chamiec,(unknown),(unknown),Daniele Donati,(unknown),Marcella Petrone,(unknown),Graham J. Riley,Silvia Terreni,Martyn Wood	25
15	Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues 2004 ·Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest,(unknown),John M. Berge,Pamela Brown,(unknown),Murray J. B. Brown,Royston C. B. Copley,Andrew K. Forrest,Dieter Hamprecht,Peter J. O’Hanlon,Darren J. Mitchell,Stephen Rittenhouse,David R. Witty	44
16	Synthesis of 2-Substituted Benzofurans and Indoles Using Functionalized Titanium Benzylidene Reagents on Solid Phase 2002 ·The Journal of Organic Chemistry ·Calum Macleod,(unknown),(unknown),Louis J. Farrugia,Dieter Hamprecht,(unknown),Richard C. Hartley	58
17	Potent synthetic inhibitors of tyrosyl tRNA synthetase derived from C-pyranosyl analogues of SB-219383 2001 ·Bioorganic & Medicinal Chemistry Letters ·Richard L. Jarvest,John M. Berge,Pamela Brown,Dieter Hamprecht,(unknown),Lucy Mensah,Peter J. O’Hanlon,Andrew J. Pope	18
18	Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of four stereoisomeric analogues of the natural product SB-219383 2000 ·Bioorganic & Medicinal Chemistry Letters ·John M. Berge,Royston C. B. Copley,Drake S. Eggleston,Dieter Hamprecht,Richard L. Jarvest,Lucy Mensah,Peter J. O’Hanlon,Andrew J. Pope	28
19	Total Synthesis of Antifungal Natural Products 2000 ·PubMed ·Anthony G. M. Barrett,Wendel W. Doubleday,(unknown),Dieter Hamprecht,Julian P. Henschke,(unknown),(unknown),Mitsuru Ohkubo,Panayiotis A. Procopiou,Gary J. Tustin,Andrew J. P. White,David J. Williams	0
20	Optically active 2H-azepines: Synthesis and rearrangement into their 3H-isomers 1996 ·Tetrahedron ·Dieter Hamprecht,(unknown),Wölfgang Steglich	17

About Dieter Hamprecht

Dieter Hamprecht is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Pharmacology, having authored 37 papers that have together received 961 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (9 papers), Receptor Mechanisms and Signaling (7 papers) and Asymmetric Synthesis and Catalysis (6 papers). The work is most often cited by research in Organic Chemistry (616 citations), Pharmacology (176 citations) and Toxicology (18 citations). Dieter Hamprecht has collaborated with scholars based in United Kingdom, Italy and Germany. Frequent co-authors include Anthony G. M. Barrett, Andrew J. P. White, Mitsuru Ohkubo, David J. Williams, David R. Witty, Peter J. O’Hanlon, Calum Macleod, Richard L. Jarvest, Richard C. Hartley and Andrew J. Pope. Their work appears in journals such as Journal of the American Chemical Society, Chemical Communications and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact